1. Home
  2. ATNM vs VRA Comparison

ATNM vs VRA Comparison

Compare ATNM & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.45

Market Cap

50.2M

Sector

Health Care

ML Signal

HOLD

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$2.38

Market Cap

60.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
VRA
Founded
2000
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
50.2M
60.6M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
ATNM
VRA
Price
$1.45
$2.38
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$4.00
$4.00
AVG Volume (30 Days)
205.6K
1.7M
Earning Date
11-14-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$90,000.00
$332,526,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.33
P/E Ratio
N/A
N/A
Revenue Growth
11.11
N/A
52 Week Low
$1.03
$1.71
52 Week High
$2.41
$5.96

Technical Indicators

Market Signals
Indicator
ATNM
VRA
Relative Strength Index (RSI) 53.39 45.67
Support Level $1.33 $2.52
Resistance Level $1.48 $2.99
Average True Range (ATR) 0.11 0.31
MACD 0.02 -0.05
Stochastic Oscillator 56.16 7.61

Price Performance

Historical Comparison
ATNM
VRA

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

Share on Social Networks: